期刊
CLINICS IN CHEST MEDICINE
卷 23, 期 1, 页码 83-+出版社
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/S0272-5231(03)00062-5
关键词
-
资金
- NCI NIH HHS [P50 CA70907] Funding Source: Medline
- NATIONAL CANCER INSTITUTE [P50CA070907] Funding Source: NIH RePORTER
There have been considerable advances made in understanding the molecular pathogenesis of lung cancer which include genetic and genetic alterations (methylation) in tumor suppressor genes as well as genetic and expression abnormalities in dominant oncogenes. In addition, autocrine and paracrine growth factors have been identified as well as inherited polymorphisms that predispose to the development of lung cancer. Many studies have been done on smoking damaged respiratory epithelium which have identified these abnormalities before histologic full fledged lung cancer has developed. All of these changes are being translated into the clinic as biomarkers for identifying persons at highest risk for developing lung cancer to aid in early diagnosis, as biomakers, for response to chemoprevention, as prognostic markers, and as targets for the development of new therapies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据